Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
BMC Neurol. 2011 Jan 24;11:9. doi: 10.1186/1471-2377-11-9.

SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis.

Author information

  • 1Laboratory of Molecular Oncogenetics, Institut Paoli-Calmettes, Marseille, France.

Abstract

BACKGROUND:

Schwannomatosis is a disease characterized by multiple non-vestibular schwannomas. Although biallelic NF2 mutations are found in schwannomas, no germ line event is detected in schwannomatosis patients. In contrast, germline mutations of the SMARCB1 (INI1) tumor suppressor gene were described in familial and sporadic schwannomatosis patients.

METHODS:

To delineate the SMARCB1 gene contribution, the nine coding exons were sequenced in a series of 56 patients affected with a variable number of non-vestibular schwannomas.

RESULTS:

Nine variants scattered along the sequence of SMARCB1 were identified. Five of them were classified as deleterious. All five patients carrying a SMARCB1 mutation had more multiple schwannomas, corresponding to 10.2% of patients with schwannomatosis. They were also diagnosed before 35 years of age.

CONCLUSIONS:

These results suggest that patients with schwannomas have a significant probability of carrying a SMARCB1 mutation. Combined with data available from other studies, they confirm the clinical indications for genetic screening of the SMARCB1 gene.

PMID:
21255467
[PubMed - indexed for MEDLINE]
PMCID:
PMC3037869
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk